Ixekizumab, sold under the brand name Taltz, is an injectable drug for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation<\/p>\n
TALTZ (ixekizumab) injection, for subcutaneous use Initial U.S. Approval: 2016 <\/strong><\/p>\n TALTZ (ixekizumab) may be accessed in India through a named-patient import process<\/strong>\u00a0with a valid doctor\u2019s prescription, and\u00a0Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing<\/strong>\u00a0and delivery of specialty medicines subject to regulatory approvals.<\/p>\n Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n Named-patient import facilitator contact details<\/strong> Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n Note:<\/strong><\/em> NEWS \/ UPDATES<\/strong><\/p>\n India Pharma Network acts solely as a facilitator for TALTZ (ixekizumab) access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice.The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.<\/p>\n","protected":false},"excerpt":{"rendered":" TALTZ\u00ae is a humanized interleukin-17A antagonist indicated for the treatment of: \u2022 patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. \u2022 adults with active psoriatic arthritis. \u2022 adults with active ankylosing spondylitis.<\/p>\nIs TALTZ (ixekizumab) available in India?<\/h4>\n
How to get TALTZ injection delivered in India?<\/h4>\n
Who can help source TALTZ injection in India legally?<\/h4>\n
\nCompany Name:<\/strong>\u00a0Indian Pharma Network (IPN)
\nAddress:<\/strong>\u00a060\/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
\nFor sourcing and import coordination of specialty medicines, contact:<\/strong>
\nMr. Tarun:<\/strong>\u00a0+91 9891 296 838
\nMr. Neeraj:<\/strong>\u00a0+91 9811 747 774
\nEmail:\u00a0info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n\n
Compliance & Disclaimer<\/h5>\n
TALTZ (ixekizumab) – for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA)\u00a0Therapy in India<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n TALTZ<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n ixekizumab<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n Injection:
\n\u2022 80 mg\/mL solution in a single-dose prefilled autoinjector
\n\u2022 80 mg\/mL solution in a single-dose prefilled syringe
\n\u2022 40 mg\/0.5 mL solution in a single-dose prefilled syringe
\n\u2022 20 mg\/0.25 mL solution in a single-dose prefilled syringe<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n Eli Lilly and Company<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n